Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0.520. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIMH NIH HHS
Grant: T32 MH019733
NIDA NIH HHS
Grant: R01 DA048533
NIDA NIH HHS
Grant: P30 DA035772
FWCI
5.43
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords